Science Daily — The University of Wisconsin School of Medicine and Public Health is among the first medical centers in the country taking part in a novel clinical trial investigating if a subject’s own stem cells can treat a form of severe coronary artery disease.

This trial is the first human Phase II adult stem cell therapy study in the U.S. Its goal is to investigate the efficacy, tolerability, and safety of blood-derived selected stem cells to improve symptoms and clinical outcomes in patients with chronic myocardial ischemia (CMI), a severe form of coronary artery disease…

“The initial results from Phase I of the trial were encouraging,” Raval says. “Subjects reported feeling better with reductions in chest pain and improved exercise capacity during the early stage of the trial. That’s encouraging to us.”…

The article also notes that “[C]oronary artery disease is the most common form of heart disease and is the leading cause of death in the United States.” The LEADING CAUSE OF DEATH in the U.S. is being treated in clinical trials with adult stem cells and there is not one word about this is the “pro-stem-cell-research” MSM. Shameful.